EJA: EUCERD Joint Action: working for rare diseases Glória Isidro

Similar documents
National Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health

PORTUGAL FINAL REPORT

Resource on the State of the Art of Rare Disease Activities in Europe

National Strategies & Action for Rare Diseases in Europe

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

Council of the European Union Brussels, 8 September 2014 (OR. en) Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE

116 Help Lines for Rare Diseases

NoRo - a reference centre for RD

Morbidity statistics in the EU

Future and Emerging Technologies. DG Information Society. European Commission

VSOP, Lupus Netherlands

Table Of Content. Strengthening voluntary cooperation between Member States to improve the health of EU citizens... 2 Summary... 3 Work Package...

European Reference Networks (ERN) Guide for patient advocates

Draft mandate Morbidity and Mortality Working Party

EUCERD Joint Action WP7 Workshop From Centres of Expertise for Rare Diseases to European Reference Networks

EU Health Programmes

Executive Report to the European Commission on newborn screening in the European Union

Developing a European Registry for Rare Anaemias

The implementation of a purchasing mechanism for hospital resource allocation in Portugal

VASCERN 1st Annual Seminar Paris, France October 2017

EU measures to support RTD and innovation activities performed by SMEs

Implementing the 3rd Health Programme. Ingrid Keller Coordinator Health Programme Consumer, Health and Food Executive Agency

Proposal for a new legal framework for data protection in EU

Preparation of the final technical report

European Haemophilia Consortium

LITHUANIA EUROPLAN NATIONAL CONFERENCE FINAL REPORT. Under the Lithuanian EU Presidency With an overview of ESTONIA and LATVIA Rare Disease Policies

2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE

EU HEALTHY GATEWAYS Joint Action Preparedness and action at points of entry (ports, airports, ground crossings)

Contribute to the Development of Solutions for the Management of Radioactive Waste

2014 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE

Member webinar: What is an ideal European Reference Network? Matt Johnson, EURORDIS 10 February 2016

STATE OF THE ART OF RARE DISEASE ACTIVITIES IN SPAIN

Annual Work Programme 2018

URBACT III Programme Manual

EUROPLAN National Conferences CONFERENCE FINAL REPORT. I. General information

PORTUGAL DATA A1 Population see def. A2 Area (square Km) see def.

EUROPEAN COMMISSION. Proposal template. Pilot Project Call PP

FIRST INTERIM REPORT

OPEN CALL FOR PROJECT TEAM EXPERTS European Standard for Patient Summary

ERA-LEARN 2020: In-Kind/ Institutional ERA-NET-COFUND- Projects An Overview

Program of the EHFCN Open house hosted by IGAS, the General Inspectorate of Health. Lisbon, 23rd-24th June

Statistical Analysis of the EPIRARE Survey on Registries Data Elements

Ethics and Governance Issues: Patient Registries for Rare Diseases

Erasmus+ Application Form. Call: A. General Information. B. Context. B.1. Project Identification

How to help the Coordinator make a successful proposal Experiences from the RINEA Project. Melissa Plath Faculty of Social Sciences UniPID

Horizon ERA-NET Cofund actions

Work Plan 2008: priorities Cinthia Menel Lemos (PHEA)

Context. Project Title. Project Acronym. Project Start Date (dd-mm-yyyy) Project Total Duration. Project End Date (dd-mm-yyyy)

AN OPPORTUNITY FOR PRIMARY CARE

CAPACITIES WORK PROGRAMME PART 3. (European Commission C (2011) 5023 of 19 July 2011) REGIONS OF KNOWLEDGE

EUROPEAN COMMISSION HEALTH AND CONSUMER PROTECTION DG. Directorate C: Public Health and Risk Assessment Unit C2 - Health information

Project Title: THE EUROPEAN PLATFORM FOR CITIZEN INVESTMENT IN RENEWABLE ENERGY Project Acronym: CITIZENERGY IEE/13/403/SI CITIZENERGY

CONSENT ADVANCE DIRECTIVES RESEARCH

UNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES

CEF Telecom Call: eid & esignature. Carlos Gómez DG CNECT H.4 e-government & Trust

Ségolène Aymé. Chair Topical Advisory Group for Rare Diseases

Open Access. Jean-François Dechamp Open Access Policy Officer European Commission Directorate-General for Research & Innovation

Strengthening Collaborations for Operating Pharmacovigilance in Europe (SCOPE) Joint Action

ERN-EYE Kick-Off Meeting brief report

Policies contributing to Health Reforms leading to improved management of Rare Diseases/ Anaemias/ Haemoglobin Disorders in Europe

Dissemination and Communication

ERN Assessment Manual for Applicants

Societal Challenge 1: Health, demographic change & wellbeing Bucharest - Romania Dr Cristina Pascual National Documentation Centre - EKT

HORIZON The New EU Framework Programme for Research and Innovation

The Third EU Health Programme

EUROPEAN JOINT PROGRAMME ON RARE DISEASES

Government Startups Session PUBLIC PROCUREMENT OF INNOVATION

Assessment of emergency medical services preparedness in the framework of national crisis management structures in EU member states

Strategic thinking across the EU through the eyes of SHIPSAN

Cross Border Health: ERN-EuroBloodNet s overview for reaching equal access to care across EU MS

Open Info Day Horizon 2020 'Health, demographic change and wellbeing'

SERBIA. Preparatory measures for full participation in Erasmus+ INSTRUMENT FOR PRE-ACCESSION ASSISTANCE (IPA II)

State of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Denmark Report

EUROPLAN National Conference organized by ACHSE in Germany 13 th and 14 th of October 2010 in Berlin CONFERENCE FINAL REPORT

Horizon Synergies with Structural Funds

Horizon 2020 Legal Documents

Document: Report on the work of the High Level Group in 2006

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

to China 2 Visit of Philippe Busquin,Commissioner for Research of EC,

CEMARA: a Web Dynamic Application Within a N-tier Architecture for Rare Diseases

Standard Proposal Templates: Project proposal (Part B)

Horizon SME Instrument

Spreading Excellence and Widening Participation in Horizon 2020

Harnessing the power of Digital Social Platforms to shake up makers and manufacturing entrepreneurs towards a European Open Manufacturing ecosystem

Citizenergy. Boa Energia. Financial Coordinator Eupportunity, Euppy

INTERNATIONAL WEEK GIESSEN 27th JUNE 2012

Patient Safety & Quality JA PaSQ

CALL FOR PROPOSALS MARE/2014/46. Terms of Reference for an EU grant under the European Maritime and Fisheries Fund

European Forum for Disaster Risk Reduction 1 (EFDRR) Concept Paper. Overview

Franco-Pakistani Research Collaboration Dr. Riaz Ahmad

CODEGOM: A governance model for clinical ontologies

2nd European Reference Networks Conference 8-9 October Lisbon, Portugal. A report by: G Porto & F Courtois

Dissemination and Communication Strategy Plan

PHIS EVALUATION REPORT

Standard procedure and guide for the coding with Orphacodes. Work Package 5. Deliverable 5.2

DISCLAIMER. This document represents a template of an application form. It must not be used for real applications to a National Agency.

SocialChallenges.eu Call for grants 2 nd Cut-off date

ERN board of Member States

Transcription:

INSA, I.P. Instituto Nacional de Saúde Dr. Ricardo Jorge EJA: EUCERD Joint Action: working for rare diseases Glória Isidro

_Introduction Joint Action is a co-funded activity between European Commission (EC) and Member States (MS) Total of 5.504.258 (five million, five hundred and four thousand and two hundred and fifty-eight Euros) = EC 54.4% (2.994.162 )+ 45.6 % MS (2.510.096 ) Project duration: 42 months from March 1 st, 2012 Action supporting the mandate of EUCERD/ expert group

_EUCERD The European Union Commitee of Experts on Rare Diseases was formally established by the European Commission Decision of 30 November 2009 (2009/872/EC) and its first mandate took place between 2010 and 2013. Since 2014 EUCERD was substituted by the European Commission Expert Group on Rare Diseases, established by Decision 2013/C 219/04 with its first meeting in Feb in Luxembourg. assisting the Commission in the monitoring, evaluating and disseminating the results of measures taken at Community and national level in the field of rare diseases; contributing to the implementation of Community actions in the field, in particular by analyzing the results and suggesting improvements to the measures taken; contributing to the preparation of Commission reports on the implementation of the Commission Communication and the Council Recommendation; delivering opinions, recommendations or reports to the Commission either at the latter s request or on its own initiative; assisting the Commission in international cooperation on matters relating to rare diseases; assisting the Commission in drawing up guidelines, recommendations and any other action defined in the Commission Communication and in the Council Recommendation; providing an annual report of its activities to the Commission. www.eucerd.eu

_Areas of Recommendation(aims): i) Improve the visibility and recognition of RD; ii) Contribute to the development of the dissemination of knowledge about RD, from specialized research through supporting health care professionals and patient empowerment; iii) Contribute to improving accessibility to quality services in providing care, from diagnosis through the social support to innovative therapies

_Associated Partners Newcastle University (Kate Bushby) INSERM Paris (Ségolène Aymé) ISS Rome (Domenica Taruscio) EURORDIS (Yann Le Cam/Dorica Dan) CIBERER (FrancescPalau) Finnish Ministry of Social Affairs and Health (FMSAH)(Helena Kääriäinen) Goethe University Hospital Frankfurt (GUHF)(Thomas Wagner) Portuguese Ministry of Health INSA (Gloria Isidro)

_ Collaborating Partners All MS and other stakeholder representatives, via EUCERD/ expert group membership Collaborating partners are the link between National and EU level activities The Expert Group on RD is therefore a key player in EJA activities Needs and opinions of MS (EUCERD meetings, workshops, national conferences, other activities) Dissemination of outputs The hope is to retain and cement this two-way relationship

_ EJA s structure WP5 Coding and classification INSERM Core Work Packages WP6 Specialized social services EURORDIS WP7 Quality assurance and the national context (CoE) CIBERER WP4 Supporting national plans ISS WP1 Management UNEW Promote consistent quality care for RD Horizontal Work Packages WP2 Communication INSERM WP8 Integration of national and international initiatives (registries, ) FMSAH &UNEW&GUHF WP3 Evaluation INSA

_ EJA Portugal ORPHANET Portugal IBMC Prof. Jorge Sequeiros Aliança, Raríssimas, Core Work Packages DGS Dr. Alexandre Diniz DGS Dr. Alexandre Diniz WP5 Coding and classification INSERM WP4 Supporting national plans ISS WP6 Specialized social services EURORDIS Promote consistent quality care for RD WP7 Quality assurance and the national context (CoE) CIBERER WP8 Integration of national and international initiatives (registries, ) FMSAH &UNEW&GUHF? Horizontal Work Packages WP1 Management UNEW WP2 Communication INSERM WP3 Evaluation INSA

WP Final objective WP1 Tomanagethejointactionandtomakesurethatitisimplementedasplanned. WP2 To ensure that the results and deliverables of the joint action will be made available to the target groups. WP3 To verify if the joint action is being implemented as planned and reaches the objectives. WP4 Support the process of elaboration and implementation of national plans and strategies for RD.(Continuation of Europlan) WP5 Contribute to the ICD11 preparation to ensure an exhaustive coding of RD and an appropriate classification; promote the codes addition for RD in other nomenclatures; promote and facilitate the Orphanet nomenclatures use in health information systems and especially data national repositories on RD patients. WP6 Publish recomendations on social services and integration of RD into social policies and services. WP7 Identifiy effective approaches of health care services towards efficient improvement of RD patients quality of life. WP8 Develop a model of sustainability for RD initiatives.

WP3 Evaluation INSA INSA s Team Glória Isidro (DGH) gloria.isidro@insa.min-saude.pt José Calheiros (CD) jose.calheiros@insa.min-saude.pt Dezso David (DGH) dezso.david@insa.min-saude.pt Cristina Furtado (DDI) cristina.furtado@insa.min-saude.pt Ausenda Machado (DEP) ausenda.machado@insa.min-saude.pt Verónica Gomez (DGH) veronica.gomez@insa.min-saude.pt

_Evaluation s strategy WP3 Evaluation INSA Monitoring of process indicators Monitoring of outputs indicators Monitoring of outcome indicators Example: N.º conferences organized Example: N.º of good practice guidelines published Example: Existing services and best practices in RD social care provision Resources Inputs Activities Outputs Outcomes Impact The overall impact will be evaluated looking at the Joint Action as a whole

_Future actions May 2014: ECRD workshop: ISS National plans 4 th Quarter2014:EurordisIntegrationofSocialCareforRD 2014/15: Cross-Border Genetic Testing sharing best practices(unew/msah) In planning: Phase 3 workshop on Indicators/DS(ISS) Final conference on NP/NS(ISS) Evaluation of EJA with Expert Group(INSA) INSA will organize one workshop in November where all partners will present their WP

Thanks to: _Kate Busby and Stephan Lynn from UNEW _ All Project Partners _WP3 Team: Cristina Furtado, Dezso David, Ausenda Machado, José Calheiros and Verónica Gomez